Month: April 2024
Advancements in EGFR-Mutant NSCLC Treatment Landscape
The treatment landscape for EGFR-mutant non-small cell lung cancer (NSCLC) has seen remarkable evolution with the emergence of targeted therapies. Here, we delve into the…